Andrew Hollman Meyer - Net Worth and Insider Trading

Andrew Hollman Meyer Net Worth

The estimated net worth of Andrew Hollman Meyer is at least $2 Million dollars as of 2025-07-23. Andrew Hollman Meyer is the Chief Business Officer of Janux Therapeutics Inc and owns about 82,139 shares of Janux Therapeutics Inc (JANX) stock worth over $2 Million. Details can be seen in Andrew Hollman Meyer's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Andrew Hollman Meyer has not made any transactions after 2025-05-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data
Unlimited Filters in All-in-One Stock Screener
Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Quick Customer Support
And Much More...

Transaction Summary of Andrew Hollman Meyer

To

Andrew Hollman Meyer Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Andrew Hollman Meyer owns 1 companies in total, including Janux Therapeutics Inc (JANX) .

Click here to see the complete history of Andrew Hollman Meyer’s form 4 insider trades.

Insider Ownership Summary of Andrew Hollman Meyer

Ticker Company Transaction Date Type of Owner
JANX Janux Therapeutics Inc 2025-05-01 Chief Business Officer

Andrew Hollman Meyer Latest Holdings Summary

Andrew Hollman Meyer currently owns a total of 1 stock. Andrew Hollman Meyer owns 82,139 shares of Janux Therapeutics Inc (JANX) as of May 1, 2025, with a value of $2 Million.

Latest Holdings of Andrew Hollman Meyer

Ticker Company Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
JANX Janux Therapeutics Inc 2025-05-01 82,139 26.46 2,173,398

Holding Weightings of Andrew Hollman Meyer


Andrew Hollman Meyer Form 4 Trading Tracker

According to the SEC Form 4 filings, Andrew Hollman Meyer has made a total of 6 transactions in Janux Therapeutics Inc (JANX) over the past 5 years, including 0 buys and 6 sells. The most-recent trade in Janux Therapeutics Inc is the sale of 3,333 shares on May 1, 2025, which brought Andrew Hollman Meyer around $106,756.

Insider Trading History of Andrew Hollman Meyer

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Andrew Hollman Meyer Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Andrew Hollman Meyer Ownership Network

Ownership Network List of Andrew Hollman Meyer

No Data

Ownership Network Relation of Andrew Hollman Meyer

Insider Network Chart


Andrew Hollman Meyer Owned Company Details

What does Janux Therapeutics Inc do?

Who are the key executives at Janux Therapeutics Inc?

Andrew Hollman Meyer is the Chief Business Officer of Janux Therapeutics Inc. Other key executives at Janux Therapeutics Inc include director & 10 percent owner Ra Capital Healthcare Fund Lp , director & Chief Executive Officer David Alan Campbell , and 10 percent owner Avalon Ventures Xi, L.p. .

Janux Therapeutics Inc (JANX) Insider Trades Summary

Over the past 18 months, Andrew Hollman Meyer made 6 insider transaction in Janux Therapeutics Inc (JANX) with a net sale of 76,669. Other recent insider transactions involving Janux Therapeutics Inc (JANX) include a net sale of 120,000 shares made by David Alan Campbell , a net sale of 4,174,180 shares made by Avalon Ventures Xi, L.p. , and a net purchase of 2,024,041 shares made by Ra Capital Healthcare Fund Lp .

In summary, during the past 3 months, insiders sold 3,333 shares of Janux Therapeutics Inc (JANX) in total and bought 0 shares, with a net sale of 3,333 shares. During the past 18 months, 6,702,385 shares of Janux Therapeutics Inc (JANX) were sold and 2,024,041 shares were bought by its insiders, resulting in a net sale of 4,678,344 shares.

Janux Therapeutics Inc (JANX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Janux Therapeutics Inc Insider Transactions

No Available Data

Andrew Hollman Meyer Mailing Address

Above is the net worth, insider trading, and ownership report for Andrew Hollman Meyer. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Andrew Hollman Meyer's mailing address is: La Jolla Ca 92037.